Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep
What is the timing
The study also showed support for cognitive performance, starting in 30 days, plus reported improvements in energy and fatiguepromoting overall vitality and wellness
Key Details Product Name BPC-157 Category Growth Peptides Status Standard SKU ATL-BPC157 Catalog Code ATL-BPC157 Available Pack Sizes 5 mg vial, 10 mg vial, Bulk API by quote MOQ 10 units Lead Time 4-6 business days Documentation COA, HPLC, MS/LC-MS, SDS on request Commercial Supply Context Atlas BioLabs presents BPC-157 for commercial sourcing, research applications, and formulation development
US$ 25.95
US$ 29.03
US$ 26.87
